[en] We previously described significant changes in GH-binding protein (GHBP) in pathological human pregnancy. There was a substantial elevation of GHBP in cases of noninsulin-dependent diabetes mellitus and a reduction in insulin-dependent diabetes mellitus. GHBP has the potential to modulate the proportion of free placental GH (PGH) and hence the impact on the maternal GH/insulin-like growth factor I (IGF-I) axis, fetal growth, and maternal glycemic status. The present study was undertaken to investigate the relationship among glycemia, GHBP, and PGH during pregnancy and to assess the impact of GHBP on the concentration of free PGH. We have extended the analysis of specimens to include measurements of GHBP, PGH, IGF-I, IGF-II, IGF-binding protein-1 (IGFBP-1), IGFSP-2, and IGFBP-3 and have related these to maternal characteristics, fetal growth, and glycemia. The simultaneous measurement of GHBP and PGH has for the first time allowed calculation of the free component of PGH and correlation of the free component to indexes of fetal growth and other endocrine markers. PGH, free PGH, IGF-I, and IGF-II were substantially decreased in IUGR at 28-30 weeks gestation (K28) and 36-38 weeks gestation (K36). The mean concentration (+/-SEM) of total PGH increased significantly from K28 to K36 (30.0 +/- 2.2 to 50.7 +/- 6.2 ng/mL; n = 40), as did the concentration of free PGH (23.4 +/- 2.3 to 43.7 +/- 6.0 ng/mL; n = 38). The mean percentage of free PGH was significantly less in IUGR than in normal subjects (67% vs. 79%; P < 0.01). Macrosomia was associated with an increase in these parameters that did not reach statistical significance. Multiple regression analysis revealed that PGH/IGF-I and IGFBP-5 account for 40% of the variance in birth weight. IGFBP-3 showed a significant correlation with IGF-I, IGF-II, and free and total PGK at K28 and K36. Noninsulin-dependent diabetes mellitus patients had a lower mean percentage of free PGH (65%; P < 0.01), and insulin-dependent diabetics had a higher mean percentage of free PGH (87%; P < 0.01) than normal subjects. Mean postprandial glucose at K28 correlated positively with PGH and free PGH (consistent with the hyperglycemic action of GH). GHBP correlated negatively with both postprandial and fasting glucose. Although GHBP correlated negatively with PGH (r = -0.52; P <.001), free PGH and total PGH correlated very closely (r = 0.98). The results are consistent with an inhibitory function for GHBP in vivo and support a critical role for placental GH and IGF-I in driving normal fetal growth.
Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
McIntyre, H. D.
Serek, R.
Crane, D. I.
Veveris-Lowe, T.
Parry, A.
Johnson, S.
Leung, K. C.
Ho, K. K. Y.
Bougoussa, M.
Hennen, Georges ; Centre Hospitalier Universitaire de Liège - CHU > Endocrinologie clinique
Igout, Ahmed ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Fung-Yee, Chan; Centre Hospitalier Universitaire de Liège - CHU > Hématologie clinique
Freinkel N., Metzger B.E. (1992) Metabolic changes in pregnancy., Wilson JD, Foster DW, eds. Williams textbook of Endocrinology, 8th Ed. Philadelphia: Saunders; 993-1005.
Gluckman P.D., Harding J.E., Oliver M.H. (1993) Mechanisms of intrauterine growth retardation: Role of fetal and maternal hormones., Muller EE, Cocchi D, Locatelli V, eds. Growth hormone and somatomedins during lifespan. New York: Springer-Verlag; 147-160.
Frankenne F., Closset J., Gomez F., Scippo M.L., Smal J., Hennen G. (1988) The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab 66:1171-1180.
Caufriez A., Frankenne F., Englert Y., Golstein J., Cantraine F., Hennen G., Copinschi G. (1990) Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol 258.
Caufriez A., Frankenne F., Hennen G., Copinschi G. (1993) Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol 265.
Goodman H.M., Tai L.-R., Ray J., Cooke N.E., Liebhaber S.A. (1991) Human growth hormone variant produces insulin-like and lipolytic responses in rat adipose tissue. Endocrinology 129:1779-1783.
Igout A., Frankenne F., L'Hermite-Baleriaux M., Martin A., Hennen G. (1995) Somatogenic and lactogenic activity of the recombinant 22kDa isoform of human placental gropwth hormone. Growth Regul 5:60-65.
Mirlesse V., Frankenne F., Alsat E., Poncelet M., Hennen G., Evain-Brion D. (1993) Placental growth hormone levels in normal pregnancy and in pregnancy with intrauterine growth retardation. Pediatr Res 34:439-442.
Chard T. (1989) Hormonal control of growth in the human fetus. J Endocrinol 123:3-9.
Wang H.S., Chard T. (1992) The role of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in the control of human fetal growth. J Endocrinol 132:11-19.
Evain-Brion D. (1994) Hormonal regulation of fetal growth. Horm Res 42:207-214.
Ferguson S., Rogers M., Chung T., Chard T., Wang H.S., Owens P., Moyse K. (1994) IGF-I and IGFBP-I in pregnancy are related to glucose metabolism and fetal growth. Proc of the 3rd Int Symp on Insulin-Like Growth Factors. Growth Regul 4(SUPPL. 1):112.
Jorgensen K.D., Svendsen O., Agergaard N., Skydsgaard K. (1991) Effect of human growth hormone on the reproduction of female rats. Pharmacol Toxicol 68:14-20.
Spencer G.S.G., Robinson G.M., Berry C.J., Dobbie P.M. (1994) Alteration of maternal growth hormone levels during pregnancy influences both fetal and postnatal growth in rats. Biol Neonate 66:112-118.
Fholenhag K.I., Sandstrom I.M., Malmlof K., Skottner A.I., Nyberg F.J. (1994) Human growth hormone does not cross the placenta of the pregnant rat. Growth Regul 4:181-187.
Baumann G., Stolar M.W., Amburn K., Barsano C.P., DeVries B.C. (1986) A specific growth-hormone binding protein in human plasma: Initial characterization. J Clin Endocrinol Metab 62:134-141.
Herington A.C., Ymer S., Stevenson J. (1986) Identification and characterization of specific binding proteins for growth hormone in normal human sera. J Clin Invest 77:1817-1823.
Barnard R., Quirk P., Waters M.J. (1989) Characterization of the growth hormone-binding protein of human serum using a panel of monoclonal antibodies. J Endocrinol 123:327-332.
Barnard R., Chan F.-Y., McIntyre H.D. (1997) Growth hormone-binding protein in normal and pathological gestation: Correlations with maternal diabetes and fetal growth. J Clin Endocrinol Metab 82:1879-1884.
Blumenfeld Z., Barkey R.J., Youdim M.B.H., Brandes J.M., Amit T. (1992) Growth hormone (GH)-binding protein regulation by estrogen, progesterone, and gonadotropins in human: The effect of ovulation induction with menopausal gonadotropins, GH and gestation. J Clin Endocrinology Metab 75:1242-1249.
Rajkovic I.A., Valiontis E., Ho K.K.Y. (1994) Direct quantitation of growth hormone binding protein (rGHBP) in human serum by a ligand immunofunctional assay: Comparison with immunoprecipitation and chromatographic methods. J Clin Endocrinol Metab 78:772-777.
Evain-Brion D., Alsat E., Igout A., Frankenne F., Hennen G. (1994) Placental growth hormone variant: Assay and clinical aspects. Acta Paediatr 83(SUPPL. 399):49-51.
Igout A., Frankenne F., McNamara M. (1993) Human placental growth hormone: A new monodonal antibody for the study of its physiopathology. Proc of the 75th Annual Meet of The Endocrine Soc.
Igout A., Van Beeumen J., Frankenne F., Scippo M.L., DeVreese B., Hennen G. (1993) Purification and biochemical characterization of recombinant human placental growth hormone produced in E. coli. Biochem J 295:719-724.
Barsano C.P., Baumann G. (1989) Editorial: Simple algebraic and graphic methods for the apportionment of hormone (and receptor) into bound and free fractions in binding equilibria; or how to calculate bound and free hormone?. Endocrinology 124:1101-1106.
Cramer S.D., Barnard R., Engbers C., Ogren L., Talamantes F. (1992) Expression of the growth hormone receptor and growth hormone binding protein during pregnancy in the mouse. Endocrinology 131:876-882.
Holly J.M.P., Biddlecombe R.A., Dunger D.B. (1988) Circadian variation of GH-dependent IGF-binding protein in diabetes and its relationship to insulin. A new role for insulin?. Clin Endocrinol (Oxf) 29:667-675.
Blum W.F., Ranke M.B., Bierich J.R. (1988) A specific radioimmunoassay for insulin-like growth factor-II: The interference of the insulin-like growth factor binding proteins can be blocked by excess insulin like growth factor-I. Acta Endocrinol (Copenh) 118:374-380.
Bjarnason R., Hagenas L., Ritzen M., Carlsson L.M.S. (1996) Growth hormone binding protein (GHBP) levels in children are positively correlated to peak insulin levels. Proc of the 10th Int Congr of Endocrinol 478.
Fisker S., Vahl N., Hansen T.B., Jorgensen J.O.L., Hagen C., Orskov H., Christiansen J.S. (1998) Growth hormone (GH) substitution for one year normalizes elevated GH-binding protein levels in GH-deficient adults secondary to a reduction in body fat. A placebo controlled trial. Growth Hormone IGF Res 8:105-112.
Florkowski C.M., Barnard R., Livesey J.H., Veveris T., Espiner E.A., Donald R.A. (1999) Growth hormone binding protein correlates strongly with leptin and percentage body fat in GH-deficient adults, is increased by GH replacement but does not predict IGF response. Growth Hormone IGF Res 9:35-40.
Baldwin S., Chung M., Chard T., Wang H.S. (1993) Insulin-like growth factor-binding-protein-1, glucose tolerance and fetal growth in human pregnancy. J Endocrinol 136:319-325.
Juul A., Kastrup K.W., Pedersen S.A., Skakkebaek N.E. (1997) Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. J Clin Endcorinol Metab 82:1195-1201.
Albiston A.L., Saffery R., Herington A.C. (1995) Cloning and characterization of the promoter for the rat insulin-like growth factor-binding protein-3 gene. Endocrinology 136:696-704.
Witznitzer A., Reece E.A., Homko C., Furman B., Mazor M., Levy J. (1998) Insulin-like growth factors, their binding proteins, and fetal macrosomia in offspring of nondiabetic women. Am J Perinatol 15:23-28.
Underwood L.E. (1996) Nutritional regulation of IGF-I and IGFBPs. J Pediatr Endocrinol Metab 9(SUPPL. 3):303-312.
Holst N., Kierulf K.H., Seppala M., Koistinen R., Jacobsen M.B. (1997) Regulation of insulin-like growth factor-binding protein-1 and progesterone secretion from human granulosa-luteal cells: Effects of octreotide and insulin. Fertil Steril 68:478-482.
Davidson M.B. (1987) Effect of growth hormone on carbohydrate and lipid metabolism. Endocr Rev 8:115-129.
Moller N., Jørgensen J.O., Schmitz O. (1990) Effects of a growth hormone pulse on total and forearm substrate fluxes in humans. Am J Physiol 258.
Lim L., Spencer S.A., McKay P., Waters M.J. (1990) Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein. Endocrinology 127:1287-1291.
Mannor D.A., Winer L.M., Shaw M.A., Baumann G. (1991) Plasma growth hormone (GH)-binding proteins: Effect on GH binding to receptors and GH action. J Clin Endocrinol Metab 73:30-34.
Hansen B.S., Hjorth S., Welinder B.S., Skriver L., De Meyts P. (1993) The growth hormone (GH)-binding protein cloned from human IM-9 lymphocytes modulates the down-regulation of GH receptors by 22- and 20-kilodalton human GH in IM-9 lymphocytes and the biological effects of the hormone in Nb2 lymphoma cells. Endocrinology 133:2809-2817.
Dattani M.T., Hindmarsh P.C., Brook C.G., Robinson I.C., Marshall N.J. (1994) Inhibition of growth hormone bioactivity by recombinant human growth hormone-binding protein in the eluted stain assay system. J Endocrinol 140:445-453.
Patel N., Alsat A., Igout A., Baron F., Hennen G., Porquet D., Evain-Brion D. (1995) Glucose inhibits placental GH secretion, in vitro. J Clin Endocrinol Metab 80:1743-1746.
Bjorklund A.O., Adamson U.K.C., Carlstrom K.A.M., Hennen G., Igout A., Lins P.E.S., Westgren L.M.R. (1998) Placental hormones during induced hypoglycaemia in pregnancy women with insulin-dependent diabetes mellitus: Evidence of an active role for placenta in hormonal counter-regulation. Br J Obstet Gynaecol 105:649-655.
Alsat E., Guibourdenche J., Couturier A., Evain-Brion D. (1998) Physiological role of placental growth hormone. Mol Cell Endocrinol 140:121-127.
Nickel B., Kardami E., Cattini P.A. (1990) Differential expression of human placental growth hormone variant and chorionic somatomammotropin in culture. Biochem J 267:653-658.
